Ho, S. Et Al. 2023. Ocrelizumab Treatment Modulates B-Cell Regulating Factors in Multiple Sclerosis. NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION , vol.10, no.2 .

Ho, S., Oswald, E., Wong, H. K., Vural, A., Yilmaz, V., Tüzün, E., ... Türkoğlu, R.(2023). Ocrelizumab Treatment Modulates B-Cell Regulating Factors in Multiple Sclerosis. NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION , vol.10, no.2.

Ho, Samantha Et Al. "Ocrelizumab Treatment Modulates B-Cell Regulating Factors in Multiple Sclerosis," NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION , vol.10, no.2, 2023

Ho, Samantha Et Al. "Ocrelizumab Treatment Modulates B-Cell Regulating Factors in Multiple Sclerosis." NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION , vol.10, no.2, 2023

Ho, S. Et Al. (2023) . "Ocrelizumab Treatment Modulates B-Cell Regulating Factors in Multiple Sclerosis." NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION , vol.10, no.2.

@article{article, author={Samantha Ho Et Al. }, title={Ocrelizumab Treatment Modulates B-Cell Regulating Factors in Multiple Sclerosis}, journal={NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION}, year=2023}